| Application no. and date | 18160057.8 (espacenet) (Federated) (European Patent Register), 20121010 | | Patent/reg. no. and date | DK/EP 3351261, 20210602 | | Publication date | 20180725 | | Priority no. and date | EP 11184644, 20111011, EP 11188625, 20111110, EP 12185108, 20120919 | | EP pub. no. and date |
EP 3351261 20180725 | | Effective date | | | Applicant/owner | Universität Zürich, Rämistrasse 71
8006 Zürich, DE | | Applicant ref. no. | V609DKEP | | Inventor | BECHER, Burkhard, Im Mattenacher 3
8124 Maur, CH,
VOM BERG, Johannes, Mattenhof 12B
8051 Zürich, CH | | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | | Opponent | | | IPC Class | A61K 38/20 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombinationslægemiddel omfattende IL-12 og et middel til blokering af T-celle-inhibitoriske molekyler i behandlingen af tumorer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
